Consistent with the expression of Il13ra1 and Il17rb on tuft cells, IL25 or IL13 stimulation of tumor organoids increased their size, while treatment of organoids with an α-IL25 neutralizing antibody resulted in reduced organoid growth (Fig. 4a). Here, IL25 is linked to neoplasm.